Skip to content

Calibration of time-densitometry for the quantification of aortic regurgitation

Calibration of time-densitometry for the quantification of aortic regurgitation - IQ-AR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41724
Enrollment
20
Registered
2015-06-01
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic valve insufficieny aortic valve leak aortic valve regurgitation

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >18y 2. At least mild (grade 1 or more) aortic regurgitation (AR) on contrast aortography or echocardiography 3. Per protocol Contrast aortography 4. Contrast aortography meets all the image quality criteria that allows quantification of AR by qRA 5. Cardiac MRI (CMRI) can be performed within 1 week of aortography 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Advanced renal impairment that precludes contrast aortography (eGFR

Design outcomes

Primary

MeasureTime frame
1. Regurgitant volume and regurgitant fraction measured by velocity encoded MRI 2. qRA-index measured on aortography

Secondary

MeasureTime frame
1. Semi-quantitative TTE measurements a. in patients without TAVI or pre-TAVI: i. Vena contracta (VC) width (mm) ii. Pressure half-time (PHT) (ms) b. only in case of TAVI: Post-TAVI: i. Circumferential extent of prosthetic valve paravalvular regurgitation ii. Diastolic flow reversal in the descending aorta 2. Quantitative TTE(pre-) / TOE (post) measurements (only in case of TAVI: pre- and post-TAVI) a. Effective regurgitant orifice area (EROA) (mm2) b. Regurgitant Volume (RV) (ml) 3. Sinning index / (AR-index) calculated from haemodynamic pressure measurements

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)